Aura Research Development from 2010 to 2026
| AURA Stock | USD 5.57 0.06 1.09% |
Research Development | First Reported 2020-03-31 | Previous Quarter 22.9 M | Current Value 22.2 M | Quarterly Volatility 6.8 M |
Check Aura Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aura Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 11.4 M, Depreciation And Amortization of 1.1 M or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.93. Aura financial statements analysis is a perfect complement when working with Aura Biosciences Valuation or Volatility modules.
Aura | Research Development | Build AI portfolio with Aura Stock |
Analyzing Aura Biosciences's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing Aura Biosciences's current valuation and future prospects.
Latest Aura Biosciences' Research Development Growth Pattern
Below is the plot of the Research Development of Aura Biosciences over the last few years. It is Aura Biosciences' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aura Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Aura Research Development Regression Statistics
| Arithmetic Mean | 31,905,006 | |
| Geometric Mean | 27,018,446 | |
| Coefficient Of Variation | 68.41 | |
| Mean Deviation | 17,479,655 | |
| Median | 19,108,000 | |
| Standard Deviation | 21,824,738 | |
| Sample Variance | 476.3T | |
| Range | 66.3M | |
| R-Value | 0.75 | |
| Mean Square Error | 225.1T | |
| R-Squared | 0.56 | |
| Significance | 0.0006 | |
| Slope | 3,225,342 | |
| Total Sum of Squares | 7621.1T |
Aura Research Development History
About Aura Biosciences Financial Statements
Aura Biosciences stakeholders use historical fundamental indicators, such as Aura Biosciences' Research Development, to determine how well the company is positioned to perform in the future. Although Aura Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aura Biosciences' assets and liabilities are reflected in the revenues and expenses on Aura Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aura Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 84.3 M | 44.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aura Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aura Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aura Biosciences Stock:Check out the analysis of Aura Biosciences Correlation against competitors. For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aura Biosciences. If investors know Aura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aura Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Aura Biosciences requires distinguishing between market price and book value, where the latter reflects Aura's accounting equity. The concept of intrinsic value - what Aura Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aura Biosciences' price substantially above or below its fundamental value.
Understanding that Aura Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aura Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aura Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.